Table 7 Efficacy of first-line treatment and non-first line treatment in lenvatinib combination treatment group
LEN combination treatment | First line treatment (n = 62) | Second line treatment (n = 8) | Third-line treatment (n = 2) | Non-first line treatment (n = 10) |
|---|---|---|---|---|
CR | 1 | 0 | 1 | 1 |
PR | 19 | 0 | 0 | 0 |
SD | 34 | 8 | 0 | 8 |
PD | 8 | 0 | 1 | 1 |
ORR | 32% | 0% | 50% | 10% |
DCR | 87% | 100% | 50% | 90% |